Concepedia

Jinny Van Doorn

JV

Statistics

Publications

4

Citations

132

H-Index

4

Active since

2021

Affiliations

Yale University(Current)

Jinny Van Doorn is an author at Yale University specializing in oncology, molecular oncology, and pharmacology.

ORCID

Publications per year

2021–2022

4

Publications

4

TOP1-DNA Trapping by Exatecan and Combination Therapy with ATR Inhibitor

Ukhyun Jo, Yasuhisa Murai, Keli Agama et al. · Molecular Cancer Therapeutics · 2022 · 53 citations · Full text

, , +16

Targeting IDH1/2 mutant cancers with combinations of ATR and PARP inhibitors

Amrita Sule, Jinny Van Doorn, Ranjini K. Sundaram et al. · NAR Cancer · 2021 · 33 citations · Full text

, , +17

Tumor-selective, antigen-independent delivery of a pH sensitive peptide-topoisomerase inhibitor conjugate suppresses tumor growth without systemic toxicity

Sophia Gayle, Robert J. Aiello, Nalin Leelatian et al. · NAR Cancer · 2021 · 30 citations · Full text

, , +17

Targeting Krebs-cycle-deficient renal cell carcinoma with Poly ADP-ribose polymerase inhibitors and low-dose alkylating chemotherapy

Daiki Ueno, Juan C. Vasquez, Amrita Sule et al. · Oncotarget · 2022 · 16 citations · Full text

, , +13

1–4 of 4